Нет интернет-соединения — показывается сохранённая версия страницы.

Fortress Biotech…

USUSD
← К скринеру

Fortress Biotech Inc (US:FBIO) — Biotechnology: Pharmaceutical Preparations. Количество бирж, на которых торгуются акции компании: 1. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.

О компании

Сайт
fortressbiotech.com
Взаимодействие с инвесторами
fortressbiotech.com/investors
Сектор
Health Care · Biotechnology: Pharmaceutical Preparations
Штаб-квартира
BAY HARBOR ISLANDS, United States
Генеральный директор
Lindsay Allan Rosenwald
Сотрудники
34
Основана
2006
Акций в обращении
33.35 млн
Свободное обращение
21.44 млн
Рыночная капитализация
73.37 млн USD
Инсайдеры
22.7%
Институциональные инвесторы
31.43%
Отрасль (SIC)
Pharmaceutical Preparations
LEI
529900DZUWSYUURECK24
Коэффициент выплат
0.4%
FCF
—
Долг
35.0 млн USD
денег больше, чем долга
Стаж дивидендов
—
Прибыль, FCF и выплаченные дивиденды — за 12 месяцев до 30.06.2026 (последний отчёт компании).
Описание

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a minocycline topical foam for the treatment of lesions of rosacea; Exelderm, an antifungal cream for topical use; Targadox, an oral doxycycline drug for the therapy of severe acne; Luxamend, a water-based emulsion for the treatment of superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, first and second-degree burns, and radiation dermatitis; and UNLOXCYT, a death-ligand 1 blocking antibody for the treatment of metastatic cutaneous squamous cell carcinoma. It also develops CUTX-101, a copper histidinate injection, which is in FDA approved stage for the treatment of Menkes disease; IV Tramadol, an intravenous formulation, which is in NDA/BLA filed stage for the treatment of post-operative acute pain; Dotinurad, a urate transporter inhibitor, which is in Phase III for the treatment of gout and chronic kidney diseases; CAEL-101, a light chain fibril-reactive monoclonal antibody, which is in Phase III for the treatment of amyloid light chain amyloidosis; and Triplex, a universal recombinant modified vaccinia ankara viral vector vaccine, which is in Phase II for the treatment of cytomegalovirus, anti-human immunodeficiency virus, non-hodgkin lymphoma, and acute lymphoblastic leukemia. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.

Биржи и тикеры

БиржаТикерВалютаЦенаТип
US USA StocksFBIOUSD2.09 +2.45%обыкновенные акции

Цена за 3 месяца

US:FBIO · USD
день роста день падения экс-дата дивиденда дата выплатыНаведите / коснитесь дня — цены открытия, закрытия, максимальная и минимальная

Дивиденды

Выплаты дивидендов не обнаружены (проверено 11.10.2026). Компания, вероятно, не выплачивает дивиденды.

Новости этой недели

За последнюю неделю новостей нет. Последняя новость: 08.09.2026.

реклама

Крупнейшие держатели

ДержательДоляАкцииДата отчета
ROSENWALD LINDSAY A (Chi…≈13.74%4.59 млн2026-03-18
WEISS MICHAEL S (Officer…≈6.82%2.28 млн2026-03-18
JIN DAVID (Chief Financi…≈4.95%1.65 млн2026-06-22
Vanguard Capital Managem…3.11%1.04 млн2026-06-30
Opaleye Management Inc.2.67%890 0002026-06-30
VANGUARD INDEX FUNDS-Van…2.09%697 8022026-06-30
Mackenzie Financial Corp…1.67%555 6762026-06-30
GSA Capital Partners LLP1.37%458 4722026-06-30
Shikiar Asset Management…0.92%305 4692026-06-30
Geode Capital Management…0.9%300 5212026-06-30
VANGUARD INDEX FUNDS-Van…0.84%279 8912026-06-30
Blackrock Inc.0.67%224 7822026-06-30
Two Sigma Investments, L…0.64%213 7862026-06-30
LOBELL JONAH JAY (Direct…≈0.58%192 3972025-12-31
Bridgeway Capital Manage…0.53%177 3682026-06-30
Vanguard Fiduciary Trust…0.5%166 3712026-06-30
Bridgeway Funds, Inc.-Ul…0.46%152 3682026-06-30
HARVEY JIMMIE (Director)≈0.44%146 7042025-12-31
Fidelity Concord Street…0.43%143 1832026-07-31
KLEIN DOV (Director)≈0.39%130 1052025-12-31
HOENLEIN MALCOLM (Direct…≈0.35%115 7472025-12-31
LORENZ KEVIN R. (Directo…≈0.3%101 0092025-12-31
iShares Trust-iShares Mi…0.26%86 9832026-07-31
LU LUCY (Director)≈0.18%61 2732024-12-31
Fidelity Concord Street…0.15%49 3202026-07-31
Fidelity Concord Street…0.11%35 8742026-07-31
EA Series Trust-EA Bridg…0.07%25 0002026-06-30
Fidelity Concord Street…0.06%18 5502026-07-31
VANGUARD Inst. INDEX Fd.…0.05%18 0512026-06-30